CN113577171A - 一种治疗泌尿系统感染的中药组合物 - Google Patents
一种治疗泌尿系统感染的中药组合物 Download PDFInfo
- Publication number
- CN113577171A CN113577171A CN202010360723.8A CN202010360723A CN113577171A CN 113577171 A CN113577171 A CN 113577171A CN 202010360723 A CN202010360723 A CN 202010360723A CN 113577171 A CN113577171 A CN 113577171A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- urinary system
- system infection
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 34
- 230000002485 urinary effect Effects 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 23
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 17
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 17
- 240000007019 Oxalis corniculata Species 0.000 claims abstract description 16
- 235000016499 Oxalis corniculata Nutrition 0.000 claims abstract description 16
- 241000427159 Achyranthes Species 0.000 claims abstract description 15
- 241000534017 Saururus chinensis Species 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 14
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 14
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 14
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 14
- 240000000233 Melia azedarach Species 0.000 claims abstract description 14
- 244000292697 Polygonum aviculare Species 0.000 claims abstract description 14
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 14
- 208000005647 Mumps Diseases 0.000 claims abstract description 13
- 208000010805 mumps infectious disease Diseases 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 241000287828 Gallus gallus Species 0.000 claims abstract description 11
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000001256 steam distillation Methods 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract 3
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract 3
- 241000205585 Aquilegia canadensis Species 0.000 claims description 18
- 241000124033 Salix Species 0.000 claims description 17
- 240000008042 Zea mays Species 0.000 claims description 17
- 241000746375 Andrographis Species 0.000 claims description 16
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 16
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 16
- 235000005822 corn Nutrition 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 13
- 244000234609 Portulaca oleracea Species 0.000 claims description 10
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 244000035851 Chrysanthemum leucanthemum Species 0.000 claims description 9
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims description 9
- 241000903946 Clematidis Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 17
- 241001127637 Plantago Species 0.000 description 15
- 231100000331 toxic Toxicity 0.000 description 13
- 230000002588 toxic effect Effects 0.000 description 13
- 210000003932 urinary bladder Anatomy 0.000 description 12
- 210000002700 urine Anatomy 0.000 description 12
- 241000207925 Leonurus Species 0.000 description 10
- 230000027939 micturition Effects 0.000 description 10
- 241000218158 Clematis Species 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 230000035619 diuresis Effects 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 241000202726 Bupleurum Species 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 210000001635 urinary tract Anatomy 0.000 description 6
- 208000019206 urinary tract infection Diseases 0.000 description 6
- 241000218176 Corydalis Species 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 241000612118 Samolus valerandi Species 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 208000020544 urinary system symptom Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 241000246044 Sophora flavescens Species 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 241000555712 Forsythia Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 244000118350 Andrographis paniculata Species 0.000 description 2
- 201000003126 Anuria Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000576429 Forsythia suspensa Species 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 241000219784 Sophora Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010046555 Urinary retention Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- -1 d-catechin Natural products 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000036244 malformation Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000000626 ureter Anatomy 0.000 description 2
- 208000000143 urethritis Diseases 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- MLFIYYDKLNZLAO-UHFFFAOYSA-N 2-aminoethane-1,1-diol Chemical compound NCC(O)O MLFIYYDKLNZLAO-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 241000722953 Akebia Species 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000189662 Calla Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007749 Cataract diabetic Diseases 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010013613 Double ureter Diseases 0.000 description 1
- 206010063044 Ectopic kidney Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 240000007890 Leonurus cardiaca Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010037597 Pyelonephritis acute Diseases 0.000 description 1
- 206010037601 Pyelonephritis chronic Diseases 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046607 Urine abnormality Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000089698 Zanthoxylum simulans Species 0.000 description 1
- 235000007244 Zea mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000001555 acute pyelonephritis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 201000006368 chronic pyelonephritis Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940089639 cornsilk Drugs 0.000 description 1
- 238000002574 cystoscopy Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000007025 diabetic cataract Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000000244 kidney pelvis Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000001231 zea mays silk Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种治疗泌尿系统感染的药物组合物及其制备方法,该药物组合物按照重量份的配比包括:石椒草8~12份、车前草10~15份、酢浆草5~10份、鸡内金3~6份、肉苁蓉30~50份、灯心草2~5份、牛膝13~20份、扁蓄15~25份、柴胡10~20份、益母草0~30份、连翘10~20份、川楝子5~10份、痄腮树2~5份、柠檬皮10~20份、三白草5~10份。制备方法包括:配料,将各原料加水浸泡1~2h,水蒸气蒸馏提取1~2h,收集一次提取液;将一次提取后的药渣加水混合均匀,再次水蒸气蒸馏提取1~2h,收集二次提取液;将两次提取液过滤并浓缩,加入辅料混合均匀,制成成品。
Description
技术领域
本发明涉及泌尿系统感染药物制备技术领域,具体涉及一种治疗泌尿系统感染的中药组合物。
背景技术
泌尿感染是由细菌直接侵入尿路而引起的炎症。诱发泌尿系感染性疾病的原因主要有以下几个方面:1)梗阻与返流;泌尿系梗阻与返流都可引起尿流动力学的异常改变,使尿液引流不畅而滞留于泌尿道内,容易招致感染。2)妊娠;妊娠期中由于机体内分泌的改变和子宫压迫输尿管下段可以引起尿液引流不畅。3)糖尿病问题;众所周知,糖尿病患者由于机体一系列代谢功能的紊乱和免疫功能的改变容易引起感染,并且一旦发生感染更不易控制。据报道糖尿病病人尿路感染的发生率比正常人高5倍。4)先天性畸形;泌尿系常有许多先天性畸形发生,如马蹄肾、异位肾、肾旋转不全、肾输尿管交界处狭窄、双输尿管双肾盂畸形、输尿管开口异位、膀胱外翻等,这些病变往往都能引起泌尿系梗阻而导致感染。5)尿路器械检查;留置导尿管、膀胱镜检查、尿道扩张术、尿路造影(逆行肾盂造影、膀胱尿道造影等),由于操作损伤粘膜或消毒不严,能使细菌带入尿路,或使原有感染灶扩散发生感染。6)其他;尿路感染常见的排尿异常是尿频、尿急、尿痛,也可见到尿失禁和尿潴留。慢性肾盂肾炎引起的慢性肾功能衰竭的早期可有多尿,后期可出现少尿或无尿。
发明内容
有鉴于此,有必要针对上述的问题,提供一种治疗泌尿系统感染的药物组合物及其制备方法。为实现上述目的,本发明采取以下的技术方案:
第一个方面,本发明提供一种治疗泌尿系统感染的药物组合物,按照重量份的配比包括:石椒草8~12份、车前草10~15份、酢浆草5~10份、鸡内金3~6份、肉苁蓉30~50份、灯心草2~5份、牛膝13~20份、扁蓄15~25份、柴胡10~20份、益母草0~30份、连翘10~20份、川楝子5~10份、痄腮树2~5份、柠檬皮10~20份、三白草5~10份。
优选的,所述药物组合物还包括:玉米须15~50份、柳树叶10~20份、川木通0~15份、穿心莲5~15份、金银花16~24份。
更优选的,所述药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、鸡内金4份、肉苁蓉35份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。
可选的,所述药物组合物还包括:黄花地丁5~10份、马齿苋5~10份、苦参1~5份、野菊花5~20份。
进一步的,所述药物组合物的剂型包括:颗粒剂、片剂、丸剂、散剂、膏剂、丹剂、胶囊剂、口服液剂、汤剂、汤剂。
第二个方面,本发明提供一种治疗泌尿系统感染的药物组合物的制备方法,包括以下步骤:
步骤1,根据上述重量份配料,将各原料加水浸泡1~2h,水蒸气蒸馏提取1~2h,收集一次提取液;
步骤2,将一次提取后的药渣加水混合均匀,再次水蒸气蒸馏提取1~2h,收集二次提取液;
步骤3,将两次提取液过滤并浓缩,加入辅料混合均匀,制成成品。
本发明所用的中药的药性如下:
石椒草:味辛、苦,性凉,归肺、胃经。具有疏风解表,清热解毒,行气活血。用于感冒,扁桃体炎,支气管炎,肺炎,肾盂肾炎,胃痛腹胀,血栓闭塞性脉管炎,腰痛,跌打损伤。
车前草:车前草为车前草科植物车前及平车前的全株,味甘,性寒。具有利尿、清热、明目、祛痰的功效。主治小便不通、淋浊、带下、尿血、黄疸、水肿、热痢、泄泻、鼻衄、目赤肿痛、喉痹、咳嗽、皮肤溃疡等。现代药学对车前草的药理研究表明,车前草具有显著的抗抑郁和抗氧自由基效果。
酢浆草:性味酸寒,无毒,入肝、肺、膀胱经。能清热利湿、凉血散淤、解毒消肿;主治湿热泄泻、痢疾、黄疸、淋证、带下、吐血、尿血、月经不调、跌打损伤、咽喉肿痛、丹毒、湿疹、痔疮、麻疹、烫火伤、蛇虫咬伤。临床上研究表明,酢浆草还具有治疗失眠和传染性肝炎的功效。
鸡内金:性味甘平。归脾、胃、小肠、膀胱经。具有健胃消食、涩精止遗、通淋化石的功效。用于食积不消、呕吐泻痢、小儿疳积、遗尿、遗精、石淋涩痛、胆胀胁痛。
肉苁蓉:味甘、咸,性温。归肾、大肠经。具有补肾阳、益精血、润肠道的功效。主肾阳虚衰;精血不足之阳痿;遗精;白浊;尿频余沥;腰痛脚弱;耳鸣目花;月经衍期;宫寒不孕;肠燥便秘。还具有抗衰老、调整内分泌、促进代谢及强壮作用,此外,肉苁蓉还能调节免疫系统、促进脱氧核糖核酸合成。
灯心草:味甘、淡,性微寒,归心、肺、小肠经,可以利尿通淋,用于治疗小便不利、淋漓失痛,另外还可以清心除烦,用于治疗口舌生疮、心烦失眠、小儿夜啼、癫痫和惊风。此外,灯芯草在治疗由心火亢盛引起的失眠方面有较好疗效。
牛膝:性味苦、甘、酸、平。归肝、肾经。具有逐瘀通经、补肝肾、强筋骨、利尿通淋、引血下行的功效。用于经闭、痛经、腰膝酸痛、筋骨无力、淋证、水肿、头痛、眩晕、牙痛、日疮、吐血、衄血。
扁蓄:性味苦、微寒。归膀胱经。该品含有萹蓄甙、槲皮甙、d-儿茶精、没食子酸、咖啡酸成分。可苦降下行,通利膀胱,苦燥又能杀虫除湿止痒,有利水通淋、杀虫止痒的作用,主要用于淋证、小便不利、黄疸、疥癣、痔疾、湿疹等症。
柴胡:性味苦、微寒,归肝、胆经。有和解表里,疏肝升阳之功效。用于感冒发热、寒热往来、疟疾、肝郁气滞、胸肋胀痛、脱肛、子宫脱垂、月经不调。
益母草:性味苦、辛,微寒。归肝、心包、膀胱经。具有活血调经、利尿消肿、清热解毒的功效。用于月经不调,痛经经闭,恶露不尽,水肿尿少,疮疡肿毒。
连翘:性味苦,凉。入心、肝、胆经。具有清热、解毒、散结、消肿的功效。治温热、丹毒、斑疹、痈疡肿毒、瘰疬、小便淋闭。临床上还用于治疗急性肾炎、紫癜病、肺脓肿、视网膜出血。
川楝子:性味苦,寒。归肝、小肠、膀胱经。具有疏肝泄热、行气止痛、杀虫的功效。用于肝郁化火,胸胁、脘腹胀痛,疝气疼痛,虫积腹痛。
痄腮树:味淡、涩,性凉。具有清热解毒的功效。主治腮腺炎。
柠檬皮:味酸甘、性平,入肝、胃经;有化痰止咳,生津,健脾的功效;主治支气管炎、百日咳、维生素C缺乏症、中暑烦渴、食欲不振、怀孕妇女胃气不和、纳减、噫气等。
三白草:性味甘、辛、寒。归肺、膀胱经。具有清热解毒、利尿消肿的功效。用于小便不利、淋沥涩痛、白带、尿路感染、肾炎水肿;外治疮疡肿毒,湿疹。临床药理学上还具有抑制金黄色葡萄球菌、伤寒杆菌、止咳、抑制眼醛糖还原酶、预防糖尿病性白内障的功效。
玉米须:味甘、淡,性平。归膀胱、肝、胆经。具有利尿消肿、清肝利胆的功效。主治水肿、小便淋沥、黄疸、胆囊炎、胆结石、高血压、糖尿病、乳汁不通。
柳树叶:味苦性凉、无毒。归肺、肾、心经。具有清热透疹、利尿解毒功效。常用于慢性气管炎,尿道炎,膀胱炎,膀胱结石,白浊,高血压,痈疽肿毒,烫火伤,关节肿痛,牙痛,痧疹,皮肤瘙痒。现代医学将其用于治疗炎症感染和地方性甲状腺肿。
苦参:味苦,性寒。归心、肝、胃、大肠、膀胱经。具有清热燥湿、杀虫、利尿的功效。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外治滴虫性阴道炎。
川木通:味苦,性寒。归心、小肠、膀胱经。具有利尿通淋、清心除烦、通经下乳的功效。用于淋证,水肿,心烦尿赤,口舌生疮,经闭乳少,湿热痹痛。
金银花:金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
穿心莲:属于一种药食两用植物,具有清热解毒、消炎、消肿止痛作用。临床研究表明,穿心莲还可以调节免疫功能、垂体-肾上腺皮质系统功能,对异丙肾上腺素引起的心肌损伤和实验性心肌梗塞缺血性损伤有一定的保护作用,以及中止妊娠、保肝利胆、抗肿瘤作用。
黄花地丁:性寒,味苦。入肺经。功能主治为:清热,解毒,利尿。治久咳痰喘,尿道炎,膀胱炎,痈疽疔疮。
马齿苋:马齿苋含有丰富的二羟乙胺、苹果酸、葡萄糖、钙、磷、铁以及维生素E、胡萝卜素、维生素B、维生素C等营养物质。马齿苋在营养上有一个突出的特点,它的ω—3脂肪酸含量高于人和植物。ω—3脂肪酸能抑制人体对胆固酸的吸收,降低血液胆固醇浓度,改善血管壁弹性,对防治心血管疾病很有利。
野菊花:野菊的叶、花及全草入药。味苦、辛、凉,清热解毒,疏风散热,散瘀,明目,降血压。防治流行性脑脊髓膜炎,预防流行性感冒、感冒,治疗高血压、肝炎、痢疾、痈疖疗疮都有明显效果。
本发明同现有技术相比,有益效果体现在:
本发明将石椒草、车前草、酢浆草、鸡内金、肉苁蓉、灯心草、牛膝、扁蓄、柴胡、益母草、连翘、川楝子、痄腮树、柠檬皮、三白草复配,设计合理,诸药合用,共凑良效,对泌尿系统感染具有良好疗效,并且还具有促进机体恢复、增强免疫力的作用。
具体实施方式
在本发明的描述中,需要说明的是,实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。
为使本发明的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明的技术方案作进一步清楚、完整地描述。需要说明的是,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1
本实施例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、鸡内金4份、肉苁蓉35份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。该汤剂的制备过程为:
(1)根据上述重量份配料,将各原料加水浸泡2h,其中水的加入量为原料总重的10倍,然后水蒸气蒸馏提取1h,收集一次提取液;
(2)将一次提取后的药渣加入原料总重10倍的水混合均匀,再次水蒸气蒸馏提取1h,收集二次提取液;
(3)将两次提取液过滤并浓缩至体积减半,既得。
实施例2
本实施例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、鸡内金4份、肉苁蓉35份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份、黄花地丁6份、马齿苋5份、苦参2份、野菊花10份。该汤剂的制备方法同实施例1。
实施例3
本实施例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草10份、车前草15份、酢浆草5份、鸡内金6份、肉苁蓉40份、灯心草3份、牛膝15份、扁蓄18份、柴胡12份、益母草15份、连翘16份、川楝子8份、痄腮树3份、柠檬皮15份、三白草7份、玉米须40份、柳树叶15份、川木通10份、穿心莲10份、金银花24份。该汤剂的制备方法同实施例1。
实施例4
本实施例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草12份、车前草12份、酢浆草10份、鸡内金3份、肉苁蓉50份、灯心草2份、牛膝13份、扁蓄25份、柴胡18份、连翘20份、川楝子10份、痄腮树5份、柠檬皮20份、三白草8份、玉米须15份、柳树叶12份、穿心莲13份、金银花18份。该汤剂的制备方法同实施例1。
对比例1
本对比例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、鸡内金4份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份、黄花地丁6份、马齿苋5份、苦参2份、野菊花10份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。该汤剂的制备方法同实施例1。
对比例2
本对比例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份、黄花地丁6份、马齿苋5份、苦参2份、野菊花10份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。该汤剂的制备方法同实施例1。
对比例3
本对比例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份、黄花地丁6份、马齿苋5份、苦参2份、野菊花10份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。该汤剂的制备方法同实施例1。
对比例4
本对比例提供一种治疗泌尿系统感染的药物组合物汤剂,该药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份、黄花地丁6份、马齿苋5份、苦参2份、野菊花10份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。该汤剂的制备方法同实施例1。
实施例5
为了验证本发明药物组合物对泌尿系统感染的治疗效果,采用动物试验进行验证,具体如下:
实验动物:尿路异物相关泌尿道感染大鼠模型90只,随机分成9个组,每组10只,试验分为治疗组(1~4)、对照组(1~4)和模型组,其中治疗组分别给予实施例1~4的汤剂,对照组给予对比例1~4的汤剂,模型组给予生理盐水作为空白对照。
试验方法为:
1、尿路异物相关泌尿道感染大鼠模型的建立:将螺旋聚乙烯管经尿道置于大鼠膀胱中,同时注入绿脓杆菌。选取病理早期表现为急性肾盂肾炎的大鼠用于试验。参考文献:Mikuniya T,Kato Y,Ida T,et al.Treatment of Pseudomonas seruginoss biofilmswith a combination of fluoroquinolones and fosfomycin in a rat urinary tractinfection model[J].J Infect Chemother,2007,13:285-290。
2、对治疗1~4组、对照1~4组和模型组的小鼠进行灌胃给药,给药量为5mL/kg,每天1次,连续7天,停药1天后收集大鼠24h尿液,进行尿中白细胞、红细胞和亚硝酸盐检测,结果如表1所示。
表1治疗组、对照组和模型组的大鼠治疗结果
表1的数据显示,采用本实施例的药物组合物,治疗1组和2组的效果相对较好,对照组的效果明显不如治疗组。因此,本实施例的药物组合物对于泌尿道感染大鼠具有显著效果。
实施例6
对实施例1~4的汤剂进行微生物检测,检测结果如表1所示。
表1微生物检测结果
项目 | 实施例1 | 实施例2 | 实施例3 | 实施例4 |
细菌总数(cfu/g) | <500 | <500 | <500 | <500 |
霉菌总数(cfu/g) | <9 | <9 | <9 | <9 |
大肠埃希菌(cfu/g) | 未检出 | 未检出 | 未检出 | 未检出 |
活螨 | 未检出 | 未检出 | 未检出 | 未检出 |
表1的数据表明,本发明实施例1~4制备的治疗泌尿系统感染的药物组合物汤剂质量合格。
实施例7
对实施例1~4的汤剂进行毒性试验,具体如下:
(1)急性毒性试验:
选取体重在30g左右的小鼠30只,随机分为两组,一组饲喂实施例2的汤剂,给药量为10mL/kg,另一组给予等量的生理盐水,每天3次,给药间隔时间为8小时,连续给药20天;记录两组的毒性反应和死亡数量。实验结果为:20天后,两组小鼠存活情况均为100%,并且饮食、饮水、体重以及其他全身状况无异常。
(2)长期毒性试验:
选取体重在30g左右的小鼠30只,随机分为两组,一组饲喂实施例2的汤剂,给药量为10mL/kg,另一组给予等量的生理盐水,每天3次,给药间隔时间为8小时,连续给药16周后停药1周;记录两组的毒性反应、死亡数量以及停药后的各项指标(体重、行为、毛发、脏器、肝肾功能、血指标)。实验结果为:16周后,两组小鼠存活情况均为100%,本实施例的汤剂对小鼠的体重、行为、毛发、脏器、肝肾功能、大小便、血象等各项指标均无明显影响;说明本发明的汤剂对小鼠长期用药后毒性小,停药后也没有异样反应,应用安全。
实施例8
将实施例1~4的汤剂进行临床实验,具体如下:
1)治疗对象:
泌尿系统感染患者,年龄在18岁以上,女性无妊娠。
2)治疗方法:
采用实施例2的汤剂。20mL/次,一天3次,七天一个疗程。严重者需要采用多个疗程。
3)疗效判定:
痊愈:治疗后泌尿系统症状消失,停药一周不复发;
显效:泌尿系统症状明显减轻50%以上;
有效:泌尿系统症状有改善,程度在50%以下;
无效:泌尿系统症状无明显改善。
4)病例选择
选择2019年5月至2019年10月在北方地区确诊的泌尿系统感染患者150名,年龄在28~65岁之间,男性88名,女性62名,这些患者均未采取任何药物干涉。严重者采用2-3个疗程,轻症以1疗程为准。
5)治疗结果
痊愈58人,显效63人,有效18人,无效11人,总有效率92.7%。
6)典型案例
案例1:患者赵某,男,61岁,尿频尿急2年左右,伴有腰酸,尿常规检测白细胞和亚硝酸盐异常,患病期间曾多次口服罗红霉素进行治疗,每次服药期2周左右,反复复发。后改用实施例2的汤剂2周,停药2天后尿常规复检,结果显示各项指标恢复正常,痊愈。
案例2:患者刘某,女,32岁,尿频尿急1个月,伴腰酸白带多,尿常规检测显示白细胞异常。服用实施例2的汤剂7天后复检,指标全部正常,痊愈。
案例3:患者张某,男43岁,工作因素(长途车司机)导致排尿不畅,尿液潴留,感觉排尿不尽,确诊为泌尿系统感染。服用实施例2的汤剂3周,停药3天后又继续服用1周,无复发,3个月后复查,指标正常。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。
Claims (6)
1.一种治疗泌尿系统感染的药物组合物,其特征在于:按照重量份的配比包括:石椒草8~12份、车前草10~15份、酢浆草5~10份、鸡内金3~6份、肉苁蓉30~50份、灯心草2~5份、牛膝13~20份、扁蓄15~25份、柴胡10~20份、益母草0~30份、连翘10~20份、川楝子5~10份、痄腮树2~5份、柠檬皮10~20份、三白草5~10份。
2.根据权利要求1所述的一种治疗泌尿系统感染的药物组合物,其特征在于:所述药物组合物还包括:玉米须15~50份、柳树叶10~20份、川木通0~15份、穿心莲5~15份、金银花16~24份。
3.根据权利要求2所述的一种治疗泌尿系统感染的药物组合物,其特征在于:所述药物组合物按照重量份的配比包括:石椒草8份、车前草10份、酢浆草7份、鸡内金4份、肉苁蓉35份、灯心草5份、牛膝14份、扁蓄15份、柴胡15份、益母草20份、连翘15份、川楝子6份、痄腮树2份、柠檬皮20份、三白草6份、玉米须20份、柳树叶12份、川木通8份、穿心莲8份、金银花16份。
4.根据权利要求1~3任意一项所述的一种治疗泌尿系统感染的药物组合物,其特征在于:所述药物组合物还包括:黄花地丁5~10份、马齿苋5~10份、苦参1~5份、野菊花5~20份。
5.根据权利要求4所述的一种治疗泌尿系统感染的药物组合物,其特征在于:所述药物组合物的剂型包括:颗粒剂、片剂、丸剂、散剂、膏剂、丹剂、胶囊剂、口服液剂、汤剂、汤剂。
6.权利要求1~5任意一项所述的药物组合物的制备方法,其特征在于:包括以下步骤:
步骤1,根据上述重量份配料,将各原料加水浸泡1~2h,水蒸气蒸馏提取1~2h,收集一次提取液;
步骤2,将一次提取后的药渣加水混合均匀,再次水蒸气蒸馏提取1~2h,收集二次提取液;
步骤3,将两次提取液过滤并浓缩,加入辅料混合均匀,制成成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010360723.8A CN113577171A (zh) | 2020-04-30 | 2020-04-30 | 一种治疗泌尿系统感染的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010360723.8A CN113577171A (zh) | 2020-04-30 | 2020-04-30 | 一种治疗泌尿系统感染的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113577171A true CN113577171A (zh) | 2021-11-02 |
Family
ID=78236893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010360723.8A Pending CN113577171A (zh) | 2020-04-30 | 2020-04-30 | 一种治疗泌尿系统感染的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113577171A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1768800A (zh) * | 2005-09-29 | 2006-05-10 | 贵州百祥制药有限责任公司 | 治疗淋病、泌尿系统感染的中药制剂及其制备方法 |
CN101569681A (zh) * | 2008-04-30 | 2009-11-04 | 刘家俊 | 一种治疗泌尿感染的中药 |
-
2020
- 2020-04-30 CN CN202010360723.8A patent/CN113577171A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1768800A (zh) * | 2005-09-29 | 2006-05-10 | 贵州百祥制药有限责任公司 | 治疗淋病、泌尿系统感染的中药制剂及其制备方法 |
CN101569681A (zh) * | 2008-04-30 | 2009-11-04 | 刘家俊 | 一种治疗泌尿感染的中药 |
Non-Patent Citations (3)
Title |
---|
方灿等: "HPLC法测定泌淋颗粒中没食子酸的含量", 《中国药事》 * |
曹田梅: "自拟清尿饮治疗老年尿路感染53例", 《中国中西医结合肾病杂志》 * |
苟晓莉: "中西医结合治疗泌尿系感染", 《内蒙古中医药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721131B (zh) | 一种治疗妇女慢性盆腔炎的中药栓剂及其制备方法 | |
CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
CN102198236B (zh) | 一种治疗急性鼻窦炎的中药组合物及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN102139030A (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN104288701A (zh) | 一种治疗胆囊炎的中药组合物 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN108096502B (zh) | 一种降尿酸代用茶及其制备方法 | |
CN105106749A (zh) | 一种普外科治疗痔疮的中药组合物 | |
CN105920186B (zh) | 一种用于治疗痔疮的中药组合物及其制备方法 | |
CN106039196B (zh) | 一种治疗高脂血症的药物组合物 | |
CN104189289B (zh) | 一种治疗急性黄疸型肝炎的中药及其制备方法 | |
CN113577171A (zh) | 一种治疗泌尿系统感染的中药组合物 | |
CN103099885A (zh) | 具有祛痤疮功能软胶囊及其制备方法 | |
CN103386101B (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN113181318A (zh) | 一种治疗痔疮的中药药膏及其制备方法 | |
CN104840864B (zh) | 一种治疗小儿脾虚型腹泻的中药制剂 | |
CN114949108B (zh) | 一种治疗前列腺炎的中药组合物及制备方法和应用 | |
CN104257871B (zh) | 用于治疗湿热毒蕴型急性网状淋巴管炎的药物组合物及其制备方法 | |
CN108785383A (zh) | 一种抗菌妇科外用药物组合物及其制备方法与应用 | |
CN103656355B (zh) | 用于治疗猪副伤寒的药物及其制备方法 | |
CN108498687B (zh) | 一种用于外阴瘙痒症的中药制剂 | |
CN105396007A (zh) | 一种防治霉菌性阴道炎的妇科外用洗液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211102 |